Inspire Corporate Bond ETF (IBD) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.65: the stock has moved about 35% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerInspire Corporate Bond ETF (IBD) trades at $23.01. Inspire Corporate Bond ETF (IBD) focuses on investing in investment-grade corporate bonds of biblically aligned U.S. companies. Sector: Financials.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for IBD: IBD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Inspire Corporate Bond ETF (IBD) Financial Services Profile
Inspire Corporate Bond ETF (IBD) offers exposure to investment-grade corporate bonds from biblically aligned U.S. companies, tracking the Inspire Corporate Bond Index. With a focus on ethical investing, IBD provides a unique fixed-income option for investors seeking values-based alignment within their portfolios, operating in the competitive asset management landscape.
What Is the Investment Thesis for IBD?
Inspire Corporate Bond ETF (IBD), with a market capitalization of $0.48 billion, presents a targeted investment in investment-grade corporate bonds of biblically aligned U.S. companies. The ETF's value proposition lies in its unique ethical screening process and adherence to the Inspire Corporate Bond Index. A key growth catalyst is the increasing investor demand for ESG (Environmental, Social, and Governance) and values-based investment products. However, the fund's performance is subject to interest rate risk and credit risk associated with the underlying bonds. Ongoing monitoring of the fund's expense ratio and tracking error relative to its benchmark is crucial for assessing its long-term value. The absence of a dividend yield may deter some income-seeking investors.
Based on FMP financials and quantitative analysis
IBD Key Highlights
Market capitalization of $0.48 billion indicates a moderate size within the ETF market.
- Beta of 0.65 suggests lower volatility compared to the overall market, potentially appealing to risk-averse investors.
- Focus on investment-grade corporate bonds provides a relatively stable fixed-income investment.
- Ethical screening process aligns with the growing demand for values-based investing.
- Replicates the Inspire Corporate Bond Index, offering a transparent and rules-based investment approach.
Who Are IBD's Competitors?
IBD is benchmarked below against 5 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BGRN iShares USD Green Bond ETF | $45.48 | +0.08% | $485M | — |
| FDHY FIDELITY ENHANCED HIGH YIELD ETF | $47.52 | +0.08% | $524M | — |
| HYEM VanEck Emerging Markets High Yield Bond ETF | $19.32 | +0.21% | $516M | — |
| HYGH iShares Interest Rate Hedged High Yield Bond ETF | $85.11 | -0.01% | $540M | — |
| IBTL iShares iBonds Dec 2031 Term Treasury ETF | $19.41 | -0.21% | $560M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IBD's Key Strengths?
Unique focus on biblically aligned companies.
- Growing demand for ESG investments.
- Transparent and rules-based investment approach.
- Relatively stable fixed-income investment.
What Are IBD's Weaknesses?
Limited investment universe compared to broad-based bond ETFs.
- Potential for higher expense ratio due to ethical screening process.
- Lack of dividend yield may deter some investors.
- Vulnerability to interest rate risk.
What Are the Key Risks for IBD?
Interest rate risk associated with fixed-income investments.
- Credit risk related to the underlying corporate bonds.
- Competition from larger asset managers with lower expense ratios.
- Changes in the Inspire Corporate Bond Index methodology.
- Market volatility and economic uncertainty.
What Threats Does IBD Face?
- Competition from larger asset managers with broader product offerings.
- Changes in interest rates and credit spreads.
- Regulatory changes impacting ESG investing.
- Negative publicity related to companies in the portfolio.
What Are IBD's Competitive Advantages?
- Unique ethical screening process based on biblical values.
- Alignment with the Inspire Corporate Bond Index.
- Brand recognition within the faith-based investment community.
- First-mover advantage in the biblically responsible investing (BRI) space.
What Does IBD Do?
The Inspire Corporate Bond ETF (IBD) was created to provide investors with a fixed-income investment option that aligns with biblically responsible investing (BRI) principles. The fund invests in investment-grade corporate bonds issued by U.S. companies that meet specific criteria related to their adherence to biblical values. IBD seeks to replicate the performance of the Inspire Corporate Bond Index, which is designed to select companies that demonstrate a commitment to these values. The ETF's investment strategy involves screening potential investments based on factors such as corporate governance, environmental stewardship, and social responsibility, as defined by Inspire Investing's BRI framework. By focusing on investment-grade bonds, IBD aims to provide a relatively stable and lower-risk fixed-income option compared to high-yield or emerging market debt. The fund's portfolio typically includes bonds from a diverse range of sectors, reflecting the broad universe of U.S. corporations that meet Inspire Investing's ethical criteria. IBD's unique approach to fixed-income investing has attracted investors who prioritize both financial returns and alignment with their values.
What Products and Services Does IBD Offer?
- Invests in investment-grade corporate bonds.
- Focuses on companies aligned with biblical values.
- Tracks the Inspire Corporate Bond Index.
- Provides exposure to U.S. corporate debt market.
- Offers a fixed-income investment option.
- Screens companies based on ethical criteria.
- Aims to provide stable returns with lower risk.
How Does IBD Make Money?
- Generates revenue through management fees charged on assets under management (AUM).
- Invests in a diversified portfolio of investment-grade corporate bonds.
- Utilizes a rules-based approach to select companies that meet ethical criteria.
- Replicates the performance of the Inspire Corporate Bond Index.
What Industry Does IBD Operate In?
The Inspire Corporate Bond ETF (IBD) operates within the asset management industry, specifically focusing on fixed-income investments. The industry is characterized by a wide range of investment strategies, including passive and active management, as well as specialized approaches such as ESG investing. The competitive landscape includes large asset managers offering broad-based bond ETFs, as well as smaller firms specializing in niche strategies. Market trends include increasing demand for ESG investments, driven by growing awareness of social and environmental issues. IBD differentiates itself through its unique focus on biblically aligned companies, catering to a specific segment of values-based investors.
Who Are IBD's Key Customers?
- Individual investors seeking values-based investments.
- Financial advisors looking for ethically screened fixed-income options.
- Faith-based organizations and institutions.
- ESG-focused investors.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 42 snapshots
| 2026-08-23 | 44 |
| 2026-08-31 | 44 |
| 2026-09-08 | 44 |
| 2026-09-16 | 44 |
| 2026-09-24 | 44 |
| 2026-10-04 | 44 |
| 2026-10-05 | 44 |
What changed?
The score has stayed at 44.
Over the same 30 days the stock moved -2.1%.
IBD Financials
Bull Case vs Bear Case
Bull Case
- Unique focus on biblically aligned companies.
- Growing demand for ESG investments.
- Transparent and rules-based investment approach.
- Relatively stable fixed-income investment.
Bear Case
- Limited investment universe compared to broad-based bond ETFs.
- Potential for higher expense ratio due to ethical screening process.
- Lack of dividend yield may deter some investors.
- Vulnerability to interest rate risk.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
IBD Latest News
-
Apple, IBD Stock Of The Day, Rebounds Bullishly After iPhone Duo Debut
Investor's Business Daily · Sep 10, 2026
-
AI Leaders Palantir, Snowflake Surge, Lead 23 Newcomers To Best Stock Lists
Investor's Business Daily · Sep 3, 2026
IBD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for IBD.
Price Targets
Wall Street price target analysis for IBD.
IBD MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for IBD; grades run from A+ (80-100) to F (below 30).
What Investors Ask About Inspire Corporate Bond ETF (IBD) — Financials
What are the main risks for IBD?
The main risks for Inspire Corporate Bond ETF (IBD) include interest rate risk, which can negatively impact the fund's value when interest rates rise. Credit risk is also a concern, as the fund invests in corporate bonds that are subject to default risk.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.